International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhou Chengzhi, Qin Yinyin, Zhao Wei, Liang Zhenyu, Li Min, Liu Dan, Bai Li, Chen Yahong, Chen Yan, Cheng Yuan, Chu Tianqing, Chu Qian, Deng Haiyi, Dong Yuchao, Fang Wenfeng, Fu Xiuhua, Gao Beili, Han Yiping, He Yong, Hong Qunying, Hu Jie, Hu Yi, Jiang Liyan, Jin Yang, Lan Fen, Li Qiang, Li Shuben, Li Wen, Li Yaqing, Liang Wenhua, Lin Gen, Lin Xinqing, Liu Ming, Liu Xiaofang, Liu Xiaoju, Liu Zhefeng, Lv Tangfeng, Mu Chuanyong, Ouyang Ming, Qin Jianwen, Ren Shengxiang, Shi Huanzhong, Shi Minhua, Su Chunxia, Su Jin, Sun Dejun, Sun Yongchang, Tang Huaping, Wang Huijuan, Wang Kai, Wang Ke, Wang Mengzhao, Wang Qi, Wang Wei, Wang Xiaoping, Wang Yuehong, Wang Zhijie, Wang Zirui, Wu Lin, Wu Di, Xie Baosong, Xie Min, Xie Xiaohong, Xie Zhanhong, Xu Shufeng, Xu Xiaoman, Yang Xia, Yin Yan, Yu Zongyang, Zhang Jian, Zhang Jianqing, Zhang Jing, Zhang Xiaoju, Zhang Yingying, Zhong Diansheng, Zhou Qing, Zhou Xiangdong, Zhou Yanbin, Zhu Bo, Zhu Zhengfei, Zou Chenxi, Zhong Nanshan, He Jianxing, Bai Chunxue, Hu Chengping, Li Weimin, Song Yong, Zhou Jianying, Han Baohui, Varga Janos, Barreiro Esther, Park Hye Yun, Petrella Francesco, Saito Yuichi, Goto Taichiro, Igai Hitoshi, Bravaccini Sara, Zanoni Michele, Solli Piergiorgio, Watanabe Satoshi, Fiorelli Alfonso, Nakada Takeo, Ichiki Yoshinobu, Berardi Rossana, Tsoukalas Nikolaos, Girard Nicolas, Rossi Antonio, Passaro Antonio, Hida Toyoaki, Li Shiyue, Chen Liang'an, Chen Rongchang
Аннотация
METHODS: A panel of experts, comprising specialists in oncology, respiratory medicine, radiology, interventional medicine, and thoracic surgery, was convened. The panel was presented with a comprehensive review of the current evidence pertaining to LC-COPD. After thorough discussions, the panel reached a consensus on 17 recommendations with over 70% agreement in voting to enhance the management of LC-COPD and optimize the care of these patients.
RESULTS: The 17 statements focused on pathogenic mechanisms (n=2), general strategies (n=4), and clinical application in COPD (n=2) and lung cancer (n=9) were developed and modified. These statements provide guidance on early screening and treatment selection of LC-COPD, the interplay of lung cancer and COPD on treatment, and considerations during treatment. This consensus also emphasizes patient-centered and personalized treatment in the management of LC-COPD.
CONCLUSIONS: The consensus highlights the need for concurrent treatment for both lung cancer and COPD in LC-COPD patients, while being mindful of the mutual influence of the two conditions on treatment and monitoring for adverse reactions.